| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/22/2008 | CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2669520A1 Methods of treating cancer using sirna molecules directed against cd24 |
| 05/22/2008 | CA2669485A1 Papaya mosaic virus-based vaccines for influenza |
| 05/22/2008 | CA2669357A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | CA2669345A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 05/22/2008 | CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668503A1 Cancerous disease modifying antibodies 180706-01 |
| 05/22/2008 | CA2668496A1 Cancerous disease modifying antibodies |
| 05/22/2008 | CA2668484A1 Cancerous disease modifying antibodies 180706-02 |
| 05/21/2008 | EP1923463A1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hal-a2-positive patient and pharmaceutical comprising the antigen |
| 05/21/2008 | EP1923400A1 Compositions and methods for the treatment of systemic lupus erythematosis |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1923386A2 Carbamate caspase inhibitors and uses thereof |
| 05/21/2008 | EP1923066A1 Composition comprising rooibos tea and conjugated linoleic acid (CLA) |
| 05/21/2008 | EP1923058A1 Coated pharmaceutical composition comprising an S1P agonist or modulator |
| 05/21/2008 | EP1923055A1 Freeze-dried pharmaceutical composition comprising an S1P agonist or modulator |
| 05/21/2008 | EP1923054A1 Fast disintegrating pharmaceutical composition comprising an S1P agonist or modulator |
| 05/21/2008 | EP1922085A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
| 05/21/2008 | EP1581238B1 Improvements in or relating to immune functions |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1379492B1 Inhibitor of monoamine uptake |
| 05/21/2008 | EP1319069B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1284740B1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with monosaccharide-based compounds |
| 05/21/2008 | EP1284734B1 Isoquinoline derivatives as protein kinase inhibitors |
| 05/21/2008 | EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use |
| 05/21/2008 | EP1227837B1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/21/2008 | EP1004315B1 Preventives and/or remedies containing anti-il-6 receptor neutralizing antibodies for reducing the excretion of urinary protein in systemic lupus erythematosus |
| 05/21/2008 | EP0924986B1 Antioxidant derived from lentil and its preparation and uses |
| 05/21/2008 | EP0807166B1 A method of preparing an undifferentiated cell |
| 05/21/2008 | CN101184739A Polycyclic oxadiazoles or isoxazoles and their use as S1P receptor ligands |
| 05/21/2008 | CN101184507A Treatment of inflammatory bowel disease (ibd) |
| 05/21/2008 | CN101184505A Soluble immunoregulatory factor |
| 05/21/2008 | CN101184497A Method of improving immune function in mammals using lactobacillus strains with certain lipids |
| 05/21/2008 | CN101182448A Method for preparing non-toxic globefish fin wine |
| 05/21/2008 | CN101181626A Transfer factor capsule and preparation method thereof |
| 05/21/2008 | CN101181612A Medicament for curing cold urticaria |
| 05/21/2008 | CN101181555A Chinese medicine prescription for hypersusceptibility as well as preparation method thereof |
| 05/21/2008 | CN101181539A New use of chinese medicine composition |
| 05/21/2008 | CN101181514A Chinese medicine health products for improving sub-health status and boosting immune function |
| 05/21/2008 | CN101181430A Chinese medicine medicament for curing rosalia lupus |
| 05/21/2008 | CN101181395A Medicine preparations for curing dermatosis and preparation method thereof |
| 05/21/2008 | CN101181351A Chinese medicine composition for resisting tiredness and reinforcing immune as well as method of making the same |
| 05/21/2008 | CN101181320A Dyer's woad root vitamin C fizzy formulation |
| 05/21/2008 | CN101181315A New purpose of Yulangsan polysaccharide |
| 05/21/2008 | CN101181309A Technique for the neutralization and health preserving of element jade wash taking natural jade as principal raw material |
| 05/21/2008 | CN101181291A Tea polyoses injection |
| 05/21/2008 | CN101181290A Pharmaceutical composition and preparation method thereof |
| 05/21/2008 | CN101181246A Compound hydrochloric acid non-sofinadine sustained-release capsules |
| 05/21/2008 | CN101181244A Cetirizine pseudoephedrine sustained-release capsules |
| 05/21/2008 | CN101181227A Solid lipid nanometer particle in-situ gel rubber preparations of biological adherent cyclosporine A and preparation method thereof |
| 05/21/2008 | CN101181062A Health food for cosmetology and delaying aging as well as preparation method thereof |
| 05/21/2008 | CN100389196C Cancer cell vaccine |
| 05/21/2008 | CN100389192C Substances for preventing and treating autoimmune diseases |
| 05/21/2008 | CN100389125C Rana grahami propyl sperm peptide, gene and variant and its pharmaceutical use |
| 05/21/2008 | CN100388941C Medicine for regulating incretion, promoting immunity, promoting tumor cell apoptosis and its preparation method |
| 05/20/2008 | US7375248 Inhibitors of matrix metalloproteinase |
| 05/20/2008 | US7375131 NF-κB inhibitors |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375110 Nicotinic cholinergic receptors modulators; pain, neurodegenerative diseases; neurotransmission dysfuctions; central and autonomic nervous systems disorders; 1'-(3-pyridyl)-spiro[1-azabicyclo[2.2.1]heptane-2,3'-pyrrolidine] |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | US7374875 Peptides having affinity for the gp120 viral protein and use thereof |
| 05/20/2008 | US7374766 Immunogenic mixture of Hepatitis B surface antigens and Human papilloma-virus; minimizes number of compounds in formulation and generates strong systemic response; vaccines |
| 05/20/2008 | US7374751 QS-21 and IL-12 as an adjuvant combination |
| 05/20/2008 | CA2469833C Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2430065C Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/20/2008 | CA2199664C Novel prodrugs for the therapy of tumors and inflammatory disorders |
| 05/20/2008 | CA2177695C Method of transmitting a biologically active material to a cell |
| 05/15/2008 | WO2008058098A2 Method of treating asthma, allergic rhinitis, and skin disorders |
| 05/15/2008 | WO2008058033A2 Soluble epoxide hydrolase inhibitors for the treatment of rheumatoid arthritis |
| 05/15/2008 | WO2008057246A2 Method for treating inflammatory disorders |
| 05/15/2008 | WO2008056634A1 Novel hydroxyindole derivative |
| 05/15/2008 | WO2008056202A2 Desloratadine crystalline forms mixtures having a low level of residual solvents |
| 05/15/2008 | WO2008056156A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 05/15/2008 | WO2008055889A1 Compositions and methods of treating oncological, inflammatory and autoimmune diseases mediated by sema4a |
| 05/15/2008 | WO2008055842A1 Substituted 6-phenyl-pyrido [2,3-d] pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same |
| 05/15/2008 | WO2008055354A1 Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods |
| 05/15/2008 | WO2008055316A1 Methods and devices for the delivery of peptides into the gastric mucosa |
| 05/15/2008 | WO2008029306A3 Thiophene derivatives as s1p1/edg1 receptor agonists |
| 05/15/2008 | WO2008028192A3 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 05/15/2008 | US20080114285 Energy-activated targeted cancer therapy |
| 05/15/2008 | US20080114057 For therapy of dermatitis conditions and skin impairments such as atopic dermatitis, contact dermatitis, allergic contact dermatitis, allergic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of hands or feet, generalized exfoliative dermatitis, stasis dermatitis |
| 05/15/2008 | US20080114042 Compound |
| 05/15/2008 | US20080114031 1,2;5,6-Di-O-isopropylidene-3-deoxy-3-[{(4-chloro-phenyl)amino}-carbonyl]-amino- alpha -D-allofuranoside; |
| 05/15/2008 | US20080114019 Immunomodulators for inducing cytokine biosynthesis, for treatment of diseases including viral and neoplastic diseases; 1-[3-(Aminooxy)propyl]-2-propyl-1H-imidazo[4,5-c]quinolin-4-amine; N-[3-(4-Amino-2-propyl-1H-imidazo[4,5-c]quinolin-1-yl)propoxy]cyclopropanecarboxamide |
| 05/15/2008 | US20080114015 NF-kB inhibitors and uses thereof |
| 05/15/2008 | US20080114006 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies |
| 05/15/2008 | US20080113995 1-Cyclopentyl-4-{2-[5-(4-methanesulfonylphenyl)[1,2,4]oxadiazol-3-yl]ethyl}piperidine; histamine-H3 receptor antagonist or inverse agonist; nervous system, cardiovascular , respiratory system, gastrointestinal system and endocrinological system disorders |
| 05/15/2008 | US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113424 Isolating dermatophagoides protein via anion exchange and hydrophobic gel adsorption |
| 05/15/2008 | US20080112983 Barn Dust Extract Providing Protection From Allergies |
| 05/15/2008 | US20080112963 Inducing adaptive immune response against a tumor or a pathogen via tissue destruction, followed by engraftment of allogenic cell adjuvants to region of tissue destruction; antitumor agents |
| 05/15/2008 | US20080112925 Qs-21 and il-12 as an adjuvant combination |
| 05/15/2008 | US20080112917 Sphingolipids' Polyalkylamines Conjugates |
| 05/15/2008 | US20080112889 Histone deacetylase 8 ( HDAC8); treating T-cell lymphoma by administering a population of autologous T-cells that have been exposed to a selective HDAC8 inhibitor composition ex vivo |